DB19226InvestigationalProtein Based Therapies
Hepcidin-25 is under investigation in clinical trial NCT03381833 (A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-dependent Beta Thalassemia).
- Also known as
- Asp-thr-his-phe-pro-ile-cys-ile-phe-cys-cys-gly-cys-cys-his-arg-ser-lys-cys-gly-met-cys-cys-lys-thr (7->23),(10->13),(11->19),(14->22)-tetrakis(disulfide) · Hepcidin-25 (human)
- Code names
- LJPC-401
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Hepcidin-25, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account